Aetion Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 288

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 20

Aetion General Information

Description

Operator of a healthcare analytics company intended to offer real-world analytics and evidence to transform real-world data into decisions. The company's platform uses everyday clinical and financial interactions of the healthcare system to unlock essential evidence about the effectiveness and value of medical treatments, enabling biopharma clients and payers to collaborate in real-time and develop therapeutic insights so that patients get the required care that is both clinically and cost-effective.

Contact Information

Website
www.aetion.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5 Penn Plaza
  • 7th Floor
  • New York, NY 10001
  • United States
+1 (844) 000-0000
Primary Industry
Decision/Risk Analysis
Vertical(s)
SaaS, HealthTech, Oncology
Corporate Office
  • 5 Penn Plaza
  • 7th Floor
  • New York, NY 10001
  • United States
+1 (844) 000-0000

Aetion Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aetion Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 15-Apr-2024 00000 Completed Generating Revenue
6. Later Stage VC (Series C) 11-May-2021 00000 00000 00000 Completed Generating Revenue
5. Later Stage VC (Series B1) 26-Aug-2020 0000 000.00 00000 Completed Generating Revenue
4. Later Stage VC (Series B1) 04-Feb-2019 0000 000.00 00000 Completed Generating Revenue
3. Later Stage VC (Series B) 14-Mar-2018 000.00 000.00 00000 Completed Generating Revenue
2. Later Stage VC (Series A) 17-May-2017 $11.2M $11.2M 000.00 Completed Generating Revenue
1. Seed Round 01-Sep-2016 Completed Startup
To view Aetion’s complete valuation and funding history, request access »

Aetion Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 0,000,000 00.000000 00 000.00 000.00 00 000.00 00.000
Series B1 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 7,589,810 $0.000100 8% $4.8 $4.8 1x $4.8 17.18%
Series A 3,238,797 $0.000100 8% $4.05 $4.05 1x $4.05 7.33%
To view Aetion’s complete cap table history, request access »

Aetion Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a healthcare analytics company intended to offer real-world analytics and evidence to transform real-world d
Decision/Risk Analysis
New York, NY
288 As of 2024
00000
0000000000 0 00000

000000

sequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum do
0000000000000 000000
Irving, TX
00 As of 0000
000.00
00000000000 000.00

000000

uis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat
0000000000 0000000 (
Philadelphia, PA
000 As of 0000
00000
00000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aetion Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pieces (Decision/Risk Analysis) Venture Capital-Backed Irving, TX 00 000.00 00000000000 000.00
HealthVerity Venture Capital-Backed Philadelphia, PA 000 00000 00000000000 00000
TriNetX Private Equity-Backed Cambridge, MA 000 00000 000000000000 00000
Doctor Evidence Venture Capital-Backed Santa Monica, CA 00 00.00 00000000000 00.00
MedNet (Healthcare Technology Systems) Venture Capital-Backed Minnetonka, MN 00 000.00 00000000000 000.00
You’re viewing 5 of 8 competitors. Get the full list »

Aetion Patents

Aetion Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11011255-B1 Template driven reporting system for a longitudinal database Active 17-Aug-2015 0000000000 00
US-10762094-B1 Patient variable language for a longitudinal database Active 17-Aug-2015 0000000000 00
US-10347370-B1 Deriving a patient level longitudinal database for rapid cycle analytics Active 17-Aug-2015 000000000 00
US-20150142821-A1 Database system for analysis of longitudinal data sets Active 18-Nov-2013 00
US-9378271-B2 Database system for analysis of longitudinal data sets Active 18-Nov-2013 00
To view Aetion’s complete patent history, request access »

Aetion Executive Team (33)

Name Title Board Seat
Carolyn Magill Chief Executive Officer & Board Member
Jeremy Rassen Co-Founder, President, Co-Chief Technology Officer and Board Director
Thomas Wright Chief Financial Officer
David Vavrasek Chief Business Officer & General Manager of Technology
Nicolle Gatto Ph.D Chief Science Officer & Senior Vice President of Scientific Research
You’re viewing 5 of 33 executive team members. Get the full list »

Aetion Board Members (16)

Name Representing Role Since
Adair Newhall Self Board Observer 000 0000
Anshul Agarwal LG Technology Ventures Board Observer 000 0000
Carolyn Magill Aetion Chief Executive Officer & Board Member 000 0000
Cathy Polinsky Self Board Member 000 0000
Cris De Luca Sanofi Ventures Board Observer 000 0000
You’re viewing 5 of 16 board members. Get the full list »

Aetion Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aetion Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds
Blue Lion Global Venture Capital Minority 000 0000 000000 0
LG Technology Ventures Corporate Venture Capital Minority 000 0000 000000 0
B Capital Group Venture Capital Minority 000 0000 000000 0
Foresite Capital Growth/Expansion Minority 000 0000 000000 0
Warburg Pincus PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 20 investors. Get the full list »

Aetion Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Replica Analytics 04-Jan-2022 0000000000 Database Software 000000 00
To view Aetion’s complete acquisitions history, request access »

Aetion FAQs

  • When was Aetion founded?

    Aetion was founded in 2012.

  • Who is the founder of Aetion?

    Michael Ruhl Ph.D, Jeremy Rassen, Allon Rauer, and Sebastian Schneeweiss MD are the founders of Aetion.

  • Who is the CEO of Aetion?

    Carolyn Magill is the CEO of Aetion.

  • Where is Aetion headquartered?

    Aetion is headquartered in New York, NY.

  • What is the size of Aetion?

    Aetion has 288 total employees.

  • What industry is Aetion in?

    Aetion’s primary industry is Decision/Risk Analysis.

  • Is Aetion a private or public company?

    Aetion is a Private company.

  • What is Aetion’s current revenue?

    The current revenue for Aetion is 00000.

  • How much funding has Aetion raised over time?

    Aetion has raised $204M.

  • Who are Aetion’s investors?

    Blue Lion Global, LG Technology Ventures, B Capital Group, Foresite Capital, and Warburg Pincus are 5 of 20 investors who have invested in Aetion.

  • Who are Aetion’s competitors?

    Pieces (Decision/Risk Analysis), HealthVerity, TriNetX, Doctor Evidence, and MedNet (Healthcare Technology Systems) are some of the 8 competitors of Aetion.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »